RESEARCH FOUNDATION FOR THE TREATMENT OF OVARIAN CANCER INC (EIN 043520881) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2000

Legal Domicile

Principal Officer

RICHARD KRONISH

Phone

6176997914

Tax Period

2024-01-01 to 2024-12-31

RESEARCH FOUNDATION FOR THE TREATMENT OF OVARIAN CANCER INC, founded in 2000, is a micro nonprofit in the Medical Research sector that reported $99K in total revenue in fiscal year 2024. Revenue surged 28% from the prior year, signaling strong growth momentum. Net assets of $2.2M represent 265 months of operating reserves.

Mission

OVARIAN CANCER RESEARCH AND EDUCATION FOR THE PROMOTION OF NOVEL THERAPY

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $98,653

Other Revenue $0

TOTAL REVENUE $98,653

Expense Breakdown

Grants Paid $100,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $100,000

Other Expenses $3,537

TOTAL EXPENSES $103,537

Year-over-Year Comparison

	2024	2023	Change
Revenue	$98,653	$77,264	+0.3%
Expenses	$103,537	$80,134	+0.3%
Net Income	$-4,884	$-2,870	+0.7%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RICHARD KRONISH	PRESIDENT/SECRETARY	10.00	Officer Director	$0	$0	$0
JOHN FLAVIN	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$98,653	$103,537	$2,176,801	$-4,884
2023	$77,264	$80,134	$2,181,134	$-2,870
2022	$262,176	$103,921	$2,184,004	$158,255
2021	$242,037	$204,559	$2,025,749	$37,478
2020	$66,395	$154,197	$2,006,771	$-87,802
2019	$258,761	$103,695	$2,176,073	$155,066
2018	$210,895	$82,100	$1,921,007	$128,795

RESEARCH FOUNDATION FOR THE TREATMENT OF OVARIAN CANCER INC